Download Files:
Products Details
Product Description
– DNDI-6148 is a novel preclinical candidate for the research of visceral leishmaniasis.
Web ID
– HY-139854
Shipping
– Room temperature
Applications
– COVID-19-immunoregulation
Molecular Formula
– C16H14BN5O3
References
– [1]Mowbray CE, et al. DNDI-6148: A Novel Benzoxaborole Preclinical Candidate for the Treatment of Visceral Leishmaniasis. J Med Chem. 2021 Nov 11;64(21):16159-16176.
CAS Number
– 2243909-59-1
Molecular Weight
– 335.13
SMILES
– O=C(C1=C(C)N(C2=NC=CC=C2)N=N1)NC3=CC=C4C(B(O)OC4)=C3
Clinical Information
– No Development Reported
Research Area
– Infection
Solubility
– 10 mM in DMSO
Target
– Parasite
Isoform
– Leishmania
Pathway
– Anti-infection
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
